α1-acid glycoprotein and α1-antitrypsin as early markers of treatment response in patients receiving the intensive phase of tuberculosis therapy

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 103, Issue 6, 2009, Pages 575-580

  Almeida, Maria Luiza Doria ^a   Barbieri, Marco Antonio ^b   Gurgel, Ricardo Q ^a   Abdurrahman, Saddiq Tsimiri ^c   Baba, Uthman Alhaji ^c   Hart, C Anthony ^d   Shenkin, Alan ^d   Silva, Ângela Maria ^a   de Souza, Luiz ^b   Cuevas, Luis Eduardo ^c  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

1 acid glycoprotein; 1 antitrypsin; Brazil; C reactive protein; Treatment response; Tuberculosis

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COPPER; OROSOMUCOID; SELENIUM; TUBERCULOSTATIC AGENT; ZINC; ALPHA1T PROTEIN, HUMAN; BIOLOGICAL MARKER; GLYCOPROTEIN; PLASMA PROTEIN;

ADULT; AGED; ARTICLE; BRAZIL; CONTROLLED STUDY; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROSPECTIVE STUDY; ADOLESCENT; METABOLISM; MIDDLE AGED; PREDICTION AND FORECASTING; SPUTUM; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ALPHA 1-ANTITRYPSIN; ANTITUBERCULAR AGENTS; BIOLOGICAL MARKERS; BLOOD PROTEINS; BRAZIL; C-REACTIVE PROTEIN; COMPLEMENT C3; COMPLEMENT C4; FEMALE; GLYCOPROTEINS; HUMANS; MALE; MIDDLE AGED; OROSOMUCOID; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 67349119521     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.11.024     Document Type: Article

References (22)

1. Keeler E., Perkins M.D., Small P., Hanson C., Reed S., Cunningham J., Aledort J.E., Hillborne L., Rafael M.E., Girosi F., and Dye C. Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 444 Suppl 1 (2006) 49-57
2. Brahmbhatt S., Black G.F., Carroll N.M., Beyers N., Salker F., Kidd M., Lukey P.T., Duncan K., van Helden P., and Walzl G. Immune markers measured before treatment predict outcome of intensive phase tuberculosis therapy. Clin Exp Immunol 146 (2006) 243-252
3. Azzurri A., Sow O.Y., Amedei A., Bah B., Diallo S., Peri G., Benagiano M., D'Elios M.M., Mantovani A., and Del Prete G. IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection. Microbes Infect 7 (2005) 1-8
4. Kaminskaia G.O., Firsova V.A., Ovsiankina E.S., Grigor'eva Z.P., and Grigor'eva E.V. Relationship of tuberculosis course in adolescents with acute phase blood proteins and genetic types of haptoglobin [in Russian]. Probl Tuberk (1997) 36-40
5. Kaminskaia G.O., Abdullaev R., Elufimova V.F., Mitinskaia L.A., and Iukhimenko N.V. The phenotypes of haptoglobin and the level of acute-phasic proteins in the sera of children with local form of intrathoracic tuberculosis [in Russian]. Probl Tuberk Bolezn Legk (2004) 35-40
6. Plit M.L., Anderson R., Van Rensburg C.E., Page-Shipp L., Blott J.A., Fresen J.L., and Feldman C. Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis. Eur Respir J 12 (1998) 351-356
7. Wong C.T., and Saha N. Changes in serum proteins (albumin, immunoglobulins and acute phase proteins) in pulmonary tuberculosis during therapy. Tubercle 71 (1990) 193-197
8. Koyanagi A., Kuffo D., Gresely L., Shenkin A., and Cuevas L.E. Relationships between serum concentrations of C-reactive protein and micronutrients, in patients with tuberculosis. Ann Trop Med Parasitol 98 (2004) 391-399
9. Ostrowski S.R., Ravn P., Hoyer-Hansen G., Ullum H., and Andersen A.B. Elevated levels of soluble urokinase receptor in serum from mycobacteria infected patients: still looking for a marker of treatment efficacy. Scand J Infect Dis 38 (2006) 1028-1032
10. Schlesinger L.S. Mycobacterium tuberculosis and the complement system. Trends Microbiol 6 (1998) 47-49 discussion 9-50
11. Mueller-Ortiz S.L., Wanger A.R., and Norris S.J. Mycobacterial protein HbhA binds human complement component C3. Infect Immun 69 (2001) 7501-7511
12. Mocchegiani E., Costarelli L., Giacconi R., Cipriano C., Muti E., and Malavolta M. Zinc-binding proteins (metallothionein and alpha-2 macroglobulin) and immunosenescence. Exp Gerontol 41 (2006) 1094-1107
13. Hochepied T., Berger F.G., Baumann H., and Libert C. Alpha(1)-acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev 14 (2003) 25-34
14. Johnson D.A., and Smith K.D. The efficacy of certain anti-tuberculosis drugs is affected by binding to alpha-1-acid glycoprotein. Biomed Chromatogr 20 (2006) 551-560
15. Singh V.K., and Fudenberg H.H. Lymphocyte stimulation in vitro by orosomucoid glycoprotein. Immunol Lett 14 (1986) 9-13
16. Boutten A., Dehoux M., Deschenes M., Rouzeau J.D., Bories P.N., and Durand G. Alpha 1-acid glycoprotein potentiates lipopolysaccharide-induced secretion of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha by human monocytes and alveolar and peritoneal macrophages. Eur J Immunol 22 (1992) 2687-2695
17. Costello M.J., Gewurz H., and Siegel J.N. Inhibition of neutrophil activation by alpha1-acid glycoprotein. Clin Exp Immunol 55 (1984) 465-472
18. Elg S.A., Mayer A.R., Carson L.F., Twiggs L.B., Hill R.B., and Ramakrishnan S. Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma. Cancer 80 (1997) 1448-1456
19. Hernandez-Pando R., Arriaga A.K., Panduro C.A., Orozco E.H., Larriva-Sahd J., and Madrid-Marina V. The response of hepatic acute phase proteins during experimental pulmonary tuberculosis. Exp Mol Pathol 65 (1998) 25-36
20. Levy H., Kalish L.A., Huntington I., Weller N., Gerard C., Silverman E.K., Celedón J.C., Pier G.B., and Weiss S.T. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol 42 (2007) 256-262
21. Barnett T.B., Gottovi D., and Johnson A.M. Protease inhibitors in chronic obstructive pulmonary disease. Am Rev Respir Dis 111 (1975) 587-593
22. Rao S., Rau P.V.P., and Sahoo R.C. Decline in alpha1-antitripsin with tuberculosis treatment - correlation with bacteriological status. Tuber Lung Dis 73 (1992) 306-307